CXCR Inhibitors

查看全部
Product Name CXCR CXCR1 CXCR2 CXCR3 CXCR4 CXCR7 CXCR6 Purity
(R)-SCH 546738 99.75%
(R,R)-CXCR2-IN-2 99.37%
(Rac)-Reparixin 99.75%
(Rac)-SCH 563705 99.78%
(S)-SCH 563705 99.94%
(±)-AMG 487
(±)-NBI-74330 99.12%
Nicotinamide N-oxide-d4
4-Amino-D-phenylalanine 99.74%
ABX-IL8 98.70%
Ac-Pro-Gly-Pro-OH 99.49%
ACKR3 agonist 1
ACT-1004-1239 98.81%
ACT-660602 99.02%
ACT-672125
ACT-777991 99.49%
Adakitug ≥99.0%
ALX 40-4C
ALX 40-4C Trifluoroacetate 99.78%
ALX-0651
AMD 3329 octahydrobromide
AMD 3465 98.24%
AMD 3465 hexahydrobromide 98.0%
AMD-3329
AMG 487 99.89%
AMG 487 (S-enantiomer) 99.94%
Anditixafortide 99.99%
Anti-CD185/CXCR5 Antibody 97.41%
Anti-CXC-ELR Antibody
Anti-CXCL12/SDF1a Antibody ≥99.0%
Anti-CXCL13 Antibody
Anti-CXCL4/PF4 Antibody 95.15%
Anti-CXCL8/IL-8 Antibody 99.51%
Anti-CXCR2 Antibody
Anti-CXCR3 Antibody (5H7)
Anti-CXCR3/GPR9/CD183 Antibody 98.45%
Anti-CXCR4/CD184 Antibody 97.08%
Anti-Human/Monkey CXCR4 Antibody (12G5)
Anti-Human/Mouse/Monkey CXCR3 Antibody (9C5) 99.33%
Anti-Mouse ACKR4 Antibody (A4Mab-3)
Anti-Mouse CCL5 Antibody (R6G9) 97.24%
Anti-Mouse CXCL10 Antibody (1F11) 97.56%
Anti-Mouse CXCL16 Antibody (12-81) 97.425%
Anti-Mouse CXCL9/MIG Antibody (MIG-2F5.5) 95.00%
Anti-Mouse CXCR2 Antibody (Cx2Mab-1)
Anti-Mouse CXCR3/CD183 Antibody (CXCR3-173) 99%
Anti-Mouse CXCR4 Antibody (Cx4Mab-1)
Anti-Mouse CXCR6 Antibody (Cx6Mab-1) 99.32%
Anti-Mouse/Human CXCL12 Antibody (K15C) 99.57%
Antileukinate
AT009
ATI-2341 99.64%
ATI-2341 TFA 98.08%
AZ10397767
AZD-5069 99.91%
AZD8309 99.98%
Balixafortide 98.20%
Balixafortide TFA 99.89%
BAM-12P
BC-1485
BMS-986184
BPRCX 714
BPRCX807
Burixafor hydrobromide 99.70%
BVT173187 99.97%
Catenarin
CAY10594 98.64%
CCR5/CXCR3-IN-1
CCR7 antagonist 1 99.55%
CCX-777 98.47%
CCX-777 formic 98.01%
CCX662
cGAS-IN-9
COG112
Corydalmine hydrochloride
Cosalane 99.50%
CTCE-0214 99.96%
CTCE-9908 99.54%
CTCE-9908 TFA
CX4338
CXCL-CXCR1/2-IN-1 99.64%
CXCL12 ligand 1
CXCL8 (54-72) 99.90%
CXCL9(74-103)
CXCR1 Human Pre-designed siRNA Set A
Cxcr1 Mouse Pre-designed siRNA Set A
Cxcr1 Rat Pre-designed siRNA Set A
CXCR2 antagonist 10
CXCR2 antagonist 2 99.32%
CXCR2 antagonist 3
CXCR2 antagonist 4
CXCR2 antagonist 5
CXCR2 antagonist 6
CXCR2 antagonist 7
CXCR2 antagonist 8 98.38%
CXCR2 Human Pre-designed siRNA Set A
Cxcr2 Mouse Pre-designed siRNA Set A
CXCR2 Probe 1
Cxcr2 Rat Pre-designed siRNA Set A
CXCR2-IN-1 99.54%
CXCR2-IN-2 99.52%
CXCR2-IN-3
CXCR2/CCR7 antagonist-1
CXCR3 antagonist 1 98.6%
CXCR3 Human Pre-designed siRNA Set A
Cxcr3 Mouse Pre-designed siRNA Set A
Cxcr3 Rat Pre-designed siRNA Set A
CXCR4 antagonist 1
CXCR4 antagonist 10 99.27%
CXCR4 antagonist 2
CXCR4 antagonist 3
CXCR4 antagonist 4
CXCR4 antagonist 5
CXCR4 antagonist 6
CXCR4 antagonist 7
CXCR4 antagonist 8
CXCR4 antagonist 9
CXCR4 Human Pre-designed siRNA Set A
CXCR4 modulator-1
CXCR4 modulator-2
Cxcr4 Mouse Pre-designed siRNA Set A
Cxcr4 Rat Pre-designed siRNA Set A
CXCR4-IN-1
CXCR4-IN-2
CXCR4-IN-3 99.69%
CXCR6 antagonist 1
CXCR6 Human Pre-designed siRNA Set A
Cxcr6 Mouse Pre-designed siRNA Set A
Cxcr6 Rat Pre-designed siRNA Set A
CXCR7 antagonist-1 99.85%
CXCR7 antagonist-1 hydrochloride 99.41%
CXCR7 modulator 1 99.27%
CXCR7 modulator 1 (Standard)
CXCR7 modulator 2 98.71%
Cyclic MKEY
Cyclic MKEY TFA 98.47%
Danirixin 98.19%
DOTA Conjugated JM#21 derivative 7
DOTA-CXCR4-L
DV1
DV1 TFA 98.53%
E70K
Eltrekibart 98.00%
Elubrixin
Elubrixin hydrochloride
Elubrixin tosylate 98.14%
EMU-116 98.53%
EPI-X4 98.91%
FC131
FC131 TFA 99.87%
FTO-IN-17
GPR35 agonist 1 99.89%
GSK699 98.80%
GSK812397
HBP08
HF50731
HF51116
HFB-100204
Hit 14
HL82624
Hypoglaucin A
HZD37-5
ICT5040
IS4
IT1t
IT1t dihydrochloride 99.77%
KRH-1636
KRH-3955 hydrochloride
KY1051
Ladarixin 99.95%
Ladarixin sodium 99.84%
LIH383
LIH383 TFA 99.83%
LN5972
LN6023 hydrochloride
LY-2624587
LY2510924 99.85%
Mavorixafor 99.66%
Mavorixafor hydrochloride 99.64%
Mavorixafor trihydrochloride 99.75%
MEDI-3185
Minecoside 99.86%
MK-1966 96.17%
ML 145 96.09%
ML 145 (Standard)
ML339 99.88%
Motixafortide 99.76%
MSX-122 98.16%
MSX-127 99.68%
MSX-130 98.00%
Mz438
Navarixin 99.33%
NBI-74330 99.76%
Nef-M1
NF279 98.5%
NI-0701 99.74%
NI-0801 99.19%
NIK-IN-3
NOTA-NHS ester 90.0%
NoxaBH3
NUCC-390 98.01%
NUCC-390 dihydrochloride 98.19%
NVP CXCR2 20
Olaptesed pegol 95.94%
Olaptesed pegol sodium 95.94%
Olaptesed pegol sodium scrambled negative control
Olopatadine 98.94%
Olopatadine-d6
Paeoniflorin-6′-O-benzene sulfonate
pCXCL8-1aa 98.13%
PD-1/PD-L1-IN-63 98.03%
PDE4D inhibitor 1
Pentixafor 99.60%
Pentixather
Peptide 78 98.13%
Peptide E5
Peptide R
Peptide R analogue 10
Peptide R TFA 98.34%
Peptide R54
Peptide R54 acetate 99.88%
PF-06465469 99.48%
PF-06747143
PF-06835375 97.71%
Polyphemusin II-Derived Peptide
PROTAC IRAK4 degrader-14
PROTAC STING Degrader-2
PS372424
PS372424 hydrochloride 95.03%
RCP168
RIPK3-IN-3 95.98%
Rugocrixan 99.54%
SB-265610 99.03%
SB-332235 98.7%
SB02024 99.70%
SB225002 99.90%
SCH 546738 98.67%
SCH 563705 99.86%
SCH-900875 98.16%
SDF-1α (human)
SDF-1α (human) TFA 98.89%
SDNUM04
SFB-AMD3465
SLW131
SMU-3k
Snail IN-1 98.27%
SQA1
SRT3109 99.68%
SRT3190 99.77%
SSB-2548
STING agonist-50
STING-IN-18
SX-517 99.90%
SX-576
SX-682 99.64%
TAK-779 99.89%
Tanimilast 99.71%
TBS6b
TC14012 99.77%
TC14012 TFA
TFAM activator 1 99.25%
TIQ-15
TJX7
TN14003
trans-VUF25471
TRK-530 sodium
UCUF-965
UNBS5162 99.07%
USL311 99.82%
VB-85247
Vimnerixin 99.16%
vMIP-II (1-21)
vMIP-II (1-21) TFA
VUF 11222 99.91%
VUF10132
VUF11207 99.98%
VUF11207 fumarate 99.94%
VUF11207 TFA
VUF11211
VUF11418
VUF5834
VX5 96.19%
WK500B
WZ811 99.80%
YU241279 99.58%
Zn-DPA-maytansinoid conjugate 1
Ulocuplumab 99.90%
Eldelumab 99.50%
Quetmolimab 99.9%
Baohuoside I 99.94%
Microhelenin C 99.55%
Hexaprofen
Burixafor
Plerixafor 99.90%
Plerixafor-d4
Herpetin
Nicotinamide N-oxide 99.85%
Nicotinamide N-oxide (Standard)
Kynurenic acid 99.93%
Kynurenic acid-d5 99.85%
Kynurenic acid sodium 99.82%
Regaloside B 99.90%
Reparixin 99.99%
Reparixin L-lysine salt 99.87%
Olopatadine hydrochloride 99.83%
Olopatadine-d3 hydrochloride
Olopatadine-d6 hydrochloride
Plerixafor octahydrochloride 99.09%
Corydalmine 99.74%
Decursin 99.92%
Decursin-d6
Benzoylpaeoniflorin 98.47%
Artemotil 99.91%
Baminercept 99.97%

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础